Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Wallentin

Showing results (131-140 of 186) with videos related to

Pageof 19
Sort By:
European Heart Journal|April 20, 1999
Reduction of myocardial damage by prolonged treatment with subcutaneous low molecular weight heparin in unstable coronary artery disease. FRISC study group. Fragmin during Instability in Coronary Artery DiseaseH Sätre, L Holmvang, G S Wagner, et al.
International Journal of Cardiac Imaging|December 1, 1993
Ambulatory ST-recording has no additional value to exercise test for identification of severe coronary lesions after an episode of unstable coronary artery disease in menJ E Karlsson, A Björkholm, P Blomstrand, et al.
European Journal of Clinical Investigation|April 1, 1984
Lipoprotein abnormalities in patients with early primary biliary cirrhosisA Aly, K Carlson, C Johansson, et al.
Heart (British Cardiac Society)|August 11, 2007
Raised interleukin-10 is an indicator of poor outcome and enhanced systemic inflammation in patients with acute coronary syndromeA Mälarstig, P Eriksson, A Hamsten, et al.
Acta Pharmacologica Et Toxicologica|August 1, 1985
Effects of dipyridamole on the glyceryl-trinitrate-induced inhibition of coronary artery muscle tone and platelet aggregation in relation to cyclic nucleotide metabolismJ Ahlner, R G Andersson, K L Axelsson, et al.
Lancet (London, England)|July 13, 2000
Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. FRISC II Investigators. Fast Revascularisation during Instability in Coronary artery diseaseL Wallentin, B Lagerqvist, S Husted, et al.
European Heart Journal|May 23, 1998
Increased fibrinogen levels are associated with persistent Chlamydia pneumoniae infection in unstable coronary artery diseaseH Toss, J Gnarpe, H Gnarpe, et al.
Coronary Artery Disease|May 16, 2001
Possible reasons for the prognostic value of troponin-T on admission in patients with ST-elevation myocardial infarctionG Frostfeldt, G Gustafsson, B Lindahl, et al.
European Heart Journal|July 2, 2002
Continuous multilead ST-monitoring identifies patients with unstable coronary artery disease who benefit from extended antithrombotic treatmentT Jernberg, P Abrahamsson, B Lindahl, et al.
Thrombosis and Haemostasis|April 8, 1998
Low-molecular weight heparin reduces the generation and activity of thrombin in unstable coronary artery diseaseM Ernofsson, F Strekerud, H Toss, et al.
Pageof 19

Showing results (131-140 of 186) with videos related to

Sort By:
Pageof 19
European Heart Journal|April 20, 1999
Reduction of myocardial damage by prolonged treatment with subcutaneous low molecular weight heparin in unstable coronary artery disease. FRISC study group. Fragmin during Instability in Coronary Artery DiseaseH Sätre, L Holmvang, G S Wagner, et al.
International Journal of Cardiac Imaging|December 1, 1993
Ambulatory ST-recording has no additional value to exercise test for identification of severe coronary lesions after an episode of unstable coronary artery disease in menJ E Karlsson, A Björkholm, P Blomstrand, et al.
European Journal of Clinical Investigation|April 1, 1984
Lipoprotein abnormalities in patients with early primary biliary cirrhosisA Aly, K Carlson, C Johansson, et al.
Heart (British Cardiac Society)|August 11, 2007
Raised interleukin-10 is an indicator of poor outcome and enhanced systemic inflammation in patients with acute coronary syndromeA Mälarstig, P Eriksson, A Hamsten, et al.
Acta Pharmacologica Et Toxicologica|August 1, 1985
Effects of dipyridamole on the glyceryl-trinitrate-induced inhibition of coronary artery muscle tone and platelet aggregation in relation to cyclic nucleotide metabolismJ Ahlner, R G Andersson, K L Axelsson, et al.
Lancet (London, England)|July 13, 2000
Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. FRISC II Investigators. Fast Revascularisation during Instability in Coronary artery diseaseL Wallentin, B Lagerqvist, S Husted, et al.
European Heart Journal|May 23, 1998
Increased fibrinogen levels are associated with persistent Chlamydia pneumoniae infection in unstable coronary artery diseaseH Toss, J Gnarpe, H Gnarpe, et al.
Coronary Artery Disease|May 16, 2001
Possible reasons for the prognostic value of troponin-T on admission in patients with ST-elevation myocardial infarctionG Frostfeldt, G Gustafsson, B Lindahl, et al.
European Heart Journal|July 2, 2002
Continuous multilead ST-monitoring identifies patients with unstable coronary artery disease who benefit from extended antithrombotic treatmentT Jernberg, P Abrahamsson, B Lindahl, et al.
Thrombosis and Haemostasis|April 8, 1998
Low-molecular weight heparin reduces the generation and activity of thrombin in unstable coronary artery diseaseM Ernofsson, F Strekerud, H Toss, et al.
Pageof 19